Carol and Richard Yu Peritoneal Dialysis Research Centre, Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong 999077, China.
Department of Nephrology, General Hospital of Ningxia Medical University, Yinchuan 750004, China.
Nutrients. 2023 Dec 20;16(1):15. doi: 10.3390/nu16010015.
Bioelectrical impedance analysis (BIA) has been extensively applied in nutritional assessments on the general population, and it is recommended in establishing the diagnosis of malnutrition and sarcopenia. The bioimpedance technique has become a promising modality through which to measure the whole-body composition in dialysis patients, where the presence of subclinical volume overload and sarcopenic obesity may be overlooked by assessing body weight alone. In the past two decades, bioimpedance devices have evolved from applying a single frequency to a range of frequencies (bioimpedance spectroscopy, BIS), in which the latter is incorporated with a three-compartment model that allows for the simultaneous measurement of the volume of overhydration, adipose tissue mass (ATM), and lean tissue mass (LTM). However, clinicians should be aware of common potential limitations, such as the adoption of population-specific prediction equations in some BIA devices. Inherent prediction error does exist in the bioimpedance technique, but the extent to which this error becomes clinically significant remains to be determined. Importantly, reduction in LTM has been associated with increased risk of frailty, hospitalization, and mortality in dialysis patients, whereas the prognostic value of ATM remains debatable. Further studies are needed to determine whether modifications of bioimpedance-derived body composition parameters through nutrition intervention can result in clinical benefits.
生物电阻抗分析(BIA)已广泛应用于一般人群的营养评估中,并且建议用于建立营养不良和肌肉减少症的诊断。生物电阻抗技术已成为一种很有前途的方法,可以在透析患者中测量全身成分,而仅通过评估体重可能会忽略存在亚临床容量超负荷和肌肉减少性肥胖的情况。在过去的二十年中,生物阻抗设备已经从应用单一频率发展到应用一系列频率(生物阻抗谱,BIS),后者与三腔模型相结合,可以同时测量水过多量、脂肪组织质量(ATM)和瘦组织质量(LTM)。然而,临床医生应该注意常见的潜在局限性,例如在某些 BIA 设备中采用特定人群的预测方程。生物电阻抗技术确实存在固有预测误差,但该误差在多大程度上具有临床意义仍有待确定。重要的是,透析患者的 LTM 减少与虚弱、住院和死亡的风险增加相关,而 ATM 的预后价值仍存在争议。需要进一步的研究来确定通过营养干预修改生物电阻抗衍生的身体成分参数是否可以带来临床益处。